Clinical trial Recruiting at 1 site Observational Ages 7 to 100

Investigating the link between oral bacteria and immune system issues in gum disease

Official title: Oral Microbial and Immunological Characterization of Patients With Immune Dysfunction

Run by National Institutes of Health Clinical Center (CC) · NCT01568697 · Data updated 2026-11-12

This study is trying to see how genetic immune problems affect gum disease and oral health by looking at people with these issues, those with severe gum disease, and healthy volunteers.

Quick facts

Study typeObservational
Ages7 Years to 100 Years
SexAll
Enrollment700 (estimated)
SponsorNational Institutes of Health Clinical Center (CC)
NIH
Drugs / interventionsradiation, Methotrexate
Locations1 site (Bethesda, Maryland)
StatusRecruiting
StartedOctober 5, 2012
Registry record updatedOctober 26, 2026
Trial IDNCT01568697 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals aged 7 and older with genetic immune defects, those with severe periodontitis, and healthy volunteers.

Probably not a fit

Patients without genetic immune defects or those who do not have periodontal disease may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore how genetic immune defects influence the development of gum disease and other oral conditions. Participants will include individuals with known genetic immune defects, those with severe periodontitis, and healthy volunteers. The study will involve screening visits that include medical history, blood work, and oral examinations to assess the presence and severity of periodontal disease and genetic factors. The goal is to understand the relationship between immune responses, oral microbiome, and susceptibility to oral infections.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of gum disease in patients with genetic immune defects.

How similar studies have gone: While this study explores a specific genetic aspect of gum disease, similar studies have shown promising results in understanding the microbiome's role in oral health.

Who can join: the full rules

Show full inclusion / exclusion criteria
* INCLUSION CRITERIA:

Subjects with Genetic Immune Defects:

Patients with a known genetic immune defect will be eligible for screening inclusion under this protocol.

* Diagnosed with a genetic immune defect
* Willing to allow genetic testing

  * 7 years old

Subjects with Severe Periodontitis of Suspected Genetic Etiology:

* History of severe periodontitis prior to age \<30
* Willing to allow genetic testing

  -\>=7 years old
* In good general health

Family members of Subjects with Severe Periodontitis of Suspected Genetic Etiology:

-Willing to allow genetic testing

-\>=7 years old

Healthy Volunteer Subjects (with/without periodontitis):

* In good general health

  -\>=18 years old
* Willing to allow genetic testing
* Have a minimum of 20 natural teeth

Inclusion Criteria for Natural History phase, all subjects:

* Diagnosis of genetic immune defect
* Presence of oral manifestation (primarily periodontitis)

Criteria for standard of care treatment:

* Active untreated disease (visible signs of tissue inflammation including erythema/edema, generalized bleeding upon probing)
* Periodontal disease defined as bone loss of \>=5mm as measured on periodontal exam.

EXCLUSION CRITERIA:

All Subjects:

* History of Hepatitis B or C
* History of HIV
* Prior radiation therapy to the head or neck
* Have an active malignancy except localized basal or squamous cell carcinoma of the skin
* Have been treated with systemic chemotherapeutics or radiation therapy within 5 years of screening
* Pregnant or lactating
* If participation in the protocol would not be safe or in the subject s best interest in the opinion of either the PI or the primary medical team.

Additional Exclusions for Healthy Volunteers:

* Diagnosis of diabetes and/or HbA1C level \>6%
* More than 3 hospitalizations in the last 3years
* Have an autoimmune disorder such as Lupus, Rheumatoid arthritis, etc.
* In the 3 months before study enrollment, have used any of the following:

  * Systemic (intravenous, intramuscular, or oral) antibiotics
  * Oral, intravenous, intramuscular, intranasal, or inhaled corticosteroids or other immunosuppressants (e.g., cyclosporine)
  * Cytokine therapy
  * Methotrexate or immunosuppressive chemotherapeutic agents
  * Large doses of commercial probiotics (\>=10\^8 colony-forming units or organisms per day); includes tablets, capsules, lozenges, chewing gum, or powders in which a probiotic is a primary component; ordinary dietary components such as fermented beverages/milks, yogurts, and foods do not apply
* Have used tobacco products (including e-cigarettes) within 1 year of screening
* Unwillingness to consent to oral biopsy
* NIH employees working in the Oral Immunity and Inflammation Unit and members of the Clinical Research Core Team will not be eligible for enrollment.

Additional Exclusions for Standard of Care Treatment at NIH:

* Mild/moderate non-active disease (absence of active inflammatory lesions)
* Subjects with urgent/complex restorative needs (ex. severe active carious lesions/fractured dentition)
* Subjects in need for advanced prosthetic needs (including implants and restorations)

Where it's running

  • National Institutes of Health Clinical Center
    Bethesda, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Niki M Moutsopoulos, D.D.S. — National Institute of Dental and Craniofacial Research (NIDCR)
  • Study coordinator: Laurie D Brenchley, R.D.H.
  • Email: laurie.brenchley@nih.gov
  • Phone: (301) 451-2551

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.